2024-09-22 - Analysis Report
## Vertex Pharmaceuticals Inc. (VRTX) Stock Analysis

**Company Overview:** Vertex Pharmaceuticals Inc. is a biotechnology company that develops and commercializes therapies for serious and life-threatening diseases, primarily focused on cystic fibrosis.

**Performance Analysis:**

1. **Relative Performance:** VRTX has outperformed the S&P 500 (VOO) by 38.45 points, currently holding a relative strength position at 73.4% within its historical range. This indicates that VRTX has generally outperformed the market over time, even though it is currently lagging slightly behind.

2. **Recent Price Movement:**  
    * **Closing Price:** $464.92
    * **5-day Moving Average:** $477.9 
    * **20-day Moving Average:** $479.21 
    * **60-day Moving Average:** $481.84
    
    VRTX is currently trading below its 5, 20, and 60-day moving averages, indicating a potential short-term downward trend.

3. **Technical Indicators:**
    * **RSI:** 32.83 - This suggests that the stock is currently in oversold territory.
    * **PPO:** -0.15 - This indicates a potential bearish trend in the stock price.
    * **Delta_Previous_Relative_Divergence:** -8.9 -  This suggests a short-term downward trend, but the negative value is less pronounced, indicating a potential turnaround.
    * **Expected_Return:** 21.41% - This indicates a potential high return on investment over the next 5 years.

4. **Recent Earnings:** 
    | Date | EPS | Revenue |
    |---|---|---|
    | 2024-08-02 | -13.92 | 2.65 B$ |  *Missed earnings estimates*
    | 2024-05-07 | 4.26 | 2.69 B$ | 
    | 2023-11-07 | 4.01 | 2.48 B$ |
    | 2023-08-02 | 3.55 | 2.49 B$ |
    | 2024-08-02 | 3.55 | 2.49 B$ |

    The most recent earnings report for 2024-08-02 showed a significant miss on earnings expectations. This might have contributed to the recent downward price trend.  

**Overall Analysis:**

VRTX is a strong company with a proven track record of outperformance. However, the recent earnings miss and the current price action suggest that the stock might be entering a period of correction. While technical indicators suggest oversold conditions and potential upside, the current price trend and recent earnings disappointment require further monitoring. 

**Recommendation:**

While the long-term prospects of VRTX remain strong, given the recent downward price movement and earnings miss, investors may consider taking a cautious approach. Monitoring further earnings reports and price action is recommended before making any investment decisions.  